CymaBay Therapeutics Inventory Turnover Ratio 2013-2018 | CBAY

CymaBay Therapeutics inventory turnover ratio from 2013 to 2018. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
CymaBay Therapeutics Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.715B $0.010B
CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $48.675B 8.76
Teva Pharmaceutical Industries (TEVA) Israel $16.168B 5.58
Mylan (MYL) United Kingdom $14.612B 6.18
Bausch Health Cos (BHC) Canada $8.444B 6.01
Dr Reddy's Laboratories (RDY) India $6.645B 26.50
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.805B 2.93
Supernus Pharmaceuticals (SUPN) United States $1.794B 16.64
Homology Medicines (FIXX) United States $0.987B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.956B 88.87
Voyager Therapeutics (VYGR) United States $0.624B 0.00
Assembly Biosciences (ASMB) United States $0.452B 0.00
Akorn (AKRX) United States $0.431B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.363B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.200B 0.00
Sol-Gel Technologies (SLGL) Israel $0.128B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.121B 0.00
Acasti Pharma (ACST) Canada $0.082B 0.00
Agile Therapeutics (AGRX) United States $0.066B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Teligent (TLGT) United States $0.058B 0.00
Evoke Pharma (EVOK) United States $0.025B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.013B 0.00